- Virginia federal judge says FDA should reconsider mifepristone restrictionsAt a time when the federal government is evaluating restrictions on medication abortion, a federal judge determined that the last administration imposed too many. A Virginia federal judge ordered…Endpoints · 2h ago↗ source
- The patent cliff is looming and CDMOs need to be prepared, Fujifilm CEO saysAs drugmakers prepare for the looming biopharma patent cliff, 2026 has so far been a year for dealmaking. Now, contract manufacturers need to broaden their services to keep up, Fujifilm Biotechnolo…Endpoints · 2h ago↗ source
- STAT+: Pharma’s drug spending deflectionJob lock, surging prescription drug costs, No Surprises Act update, and more from STAT's Health Care Inc.STAT